Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • GlaxoSmithKline, Medical Research Council, NIH, Wellcome Trust infectious news

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Medical Research Council, London, U.K. National Institutes of Health, Bethesda, Md. Wellcome Trust, London, U.K. Business: Infectious The Wellcome Trust, the Medical…

    Published on 9/1/2014
  • Hospira, Food and Drug Administration neurology news

    Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Food and Drug Administration, Silver Spring, Md. Business: Neurology Hospira filed suit against FDA in the U.S. District Court for the District of Maryland alleging that FDAs …

    Published on 9/1/2014
  • Immune Design, Theravectys infectious, cancer news

    Immune Design Corp. (NASDAQ:IMDZ), Seattle, Wash. Theravectys S.A., Paris, France Business: Infectious, Cancer Theravectys filed a suit against Immune Design in the Delaware Court of Chancery. The suit alleges that …

    Published on 9/1/2014
  • NantWorks, Providence Health & Services Corp. genomics news

    NantWorks LLC, Los Angeles, Calif. Providence Health & Services Corp., Renton, Wash. Business: Genomics NantWorks NantHealth subsidiary partnered with healthcare system Providence to form a clinical genomic network for …

    Published on 9/1/2014
  • NewLink, U.S. Department of Defense infectious news

    NewLink Genetics Corp. (NASDAQ:NLNK), Ames, Iowa U.S. Department of Defense, Washington, D.C. Business: Infectious NewLink said its BioProtection Systems Corp. subsidiary received a $1 million letter contract from the …

    Published on 9/1/2014
  • PharmAthene, Siga, U.S. Department of Health and Human Services infectious news

    PharmAthene Inc. (NYSE-M:PIP), Annapolis, Md. Siga Technologies Inc. (NASDAQ:SIGA), New York, N.Y. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious PharmAthene disclosed in its 2Q14 …

    Published on 9/1/2014
  • Pharmaxis pulmonary news

    Pharmaxis Ltd. (ASX:PXS; Pink:PXSLY), Frenchs Forest, Australia Business: Pulmonary On Aug. 1, Pharmaxis filed suit in the Supreme Court of the State of New York alleging that NovaQuest Capital Management breached a …

    Published on 9/1/2014
  • TNI BioTech cancer, inflammation, infectious news

    TNI BioTech Inc. (OTCQB:TNIB), Bethesda, Md. Business: Cancer, Inflammation, Infectious TNI BioTech extended the record date to Sept. 30 from July 15 on which all shareholders on record will receive one share of its …

    Published on 9/1/2014
  • United Therapeutics, Novartis cardiovascular, generics news

    United Therapeutics Corp. (NASDAQ:UTHR), Silver Spring, Md. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Cardiovascular, Generics The U.S. District Court for the District of New Jersey ruled that …

    Published on 9/1/2014
  • BioCryst, NIH infectious news

    BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), Durham, N.C. National Institutes of Health, Bethesda, Md. Business: Infectious BioCryst said NIHs National Institute of Allergy and Infectious Disease (NIAID) exercised …

    Published on 8/18/2014
  • Emergent BioSolutions, U.S. Centers for Disease Control and Prevention infectious news

    Emergent BioSolutions Inc. (NYSE:EBS), Rockville, Md. U.S. Centers for Disease Control and Prevention, Atlanta, Ga. Business: Infectious Emergent said the CDC exercised options under a 2012 award valued at $18.9 million…

    Published on 8/18/2014
  • Gilead, Roche infectious news

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Infectious Gilead disclosed in an SEC filing last week that an arbitration panel ruled that Roche failed…

    Published on 8/18/2014
  • Google other news

    Google Inc. (NASDAQ:GOOG), Mountain View, Calif. Business: Other Google began the pilot stage of the Baseline Study to collect bodily fluids, including blood and saliva, from 175 healthy volunteers. The company said it …

    Published on 8/18/2014
  • Knight Therapeutics infectious news

    Knight Therapeutics Inc. (TSX:GUD), Westmount, Quebec Business: Infectious Knight hired an investment bank to sell its neglected tropical disease Priority Review voucher. Knight received the voucher from FDA in March …

    Published on 8/18/2014
  • LTS Lohamnn Therapie-Systeme AG, Novartis, BWK GmbH, dievini Hopp BioTech drug delivery news

    LTS Lohamnn Therapie-Systeme AG, Andernach, Germany Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland BWK GmbH, Stuttgart, Germany dievini Hopp Biotech Holding GmbH & Co. KG, Walldorf, Germany Business: Drug delivery…

    Published on 8/18/2014
  • Sinovac, Beijing Centers for Disease Control and Prevention infectious news

    Sinovac Biotech Ltd. (NASDAQ:SVA), Beijing, China Beijing Centers for Disease Control and Prevention, Beijing, China Business: Infectious Sinovac said the Beijing CDC selected Sinovac as a supplier of seasonal influenza…

    Published on 8/18/2014
  • Soligenix, U.S. Department of Health and Human Services, NIH other news

    Soligenix Inc. (OTCBB:SNGX), Princeton, N.J. U.S. Department of Health and Human Services, Washington, D.C. National Institutes of Health, Bethesda, Md. Business: Other Soligenix said NIHs National Institute of Allergy …

    Published on 8/18/2014
  • UCB neurology, autoimmune, inflammation news

    UCB Group (Euronext:UCB), Brussels, Belgium Business: Neurology, Autoimmune, Inflammation UCB joined an online portal from software provider ideaPoint Inc. (Quincy, Mass.) through which researchers can request access to…

    Published on 8/18/2014
  • BGI, University of Birmingham high throughput screening, genomics news

    BGI, Shenzhen, China University of Birmingham, Birmingham, U.K. Business: High throughput screening, Genomics BGI and the University of Birmingham partnered to create the Joint Centre for Environmental Omics. JCEO will …

    Published on 8/11/2014
  • Environmental Protection Agency, Food and Drug Administration, NIH other news

    Environmental Protection Agency (EPA), Washington, D.C. Food and Drug Administration, Silver Spring, Md. National Institutes of Health, Bethesda, Md. Business: Other NIHs National Center for Advancing Translational …

    Published on 8/11/2014
  • Express Scripts other news

    Express Scripts Holding Co. (NASDAQ:ESRX), St. Louis, Mo. Business: Other Pharmacy benefit manager Express Scripts released a list of 66 therapies it will not cover starting Jan.1, 2015. The list includes 25 drugs it …

    Published on 8/11/2014
  • Mapp Biopharmaceutical infectious news

    Mapp Biopharmaceutical Inc., San Diego, Calif. Business: Infectious Mapp is increasing production of its ZMapp Ebola treatment as quickly as possible after reports of the compounds efficacy in two Americans infected in …

    Published on 8/11/2014
  • Amgen biopharmaceuticals news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Business: Biopharmaceuticals Amgen disclosed in its 2Q14 results that its board approved a plan to reduce headcount by about 12-15%, or 2,400-2,900, companywide through …

    Published on 8/4/2014
  • Aptiv Solutions, Eli Lilly, J&J, Novartis, Pfizer, Roche other news

    Aptiv Solutions, Reston, Va. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Pfizer Inc. (NYSE:PFE), New York, N.Y.…

    Published on 8/4/2014
  • BioMarin, Regeneron, Sanofi other news

    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Novato, Calif. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Sanofi (Euronext:SAN;NYSE:SNY), Paris, France Business: Other BioMarin said it sold a Priority …

    Published on 8/4/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993